CN Patent

CN1791592B — 免疫抑制剂化合物和组合物

Assigned to IRM LLC · Expires 2012-07-04 · 14y expired

What this patent protects

本发明涉及免疫抑制剂、它们的制备方法、它们的用途和含有它们的药物组合物。本发明提供一类新颖的化合物，可用于治疗或预防由淋巴细胞相互作用介导的疾病或障碍、特别是与EDG受体介导的信号转导有关的疾病。

USPTO Abstract

本发明涉及免疫抑制剂、它们的制备方法、它们的用途和含有它们的药物组合物。本发明提供一类新颖的化合物，可用于治疗或预防由淋巴细胞相互作用介导的疾病或障碍、特别是与EDG受体介导的信号转导有关的疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN1791592B
Jurisdiction
CN
Classification
—
Expires
2012-07-04
Drug substance claim
No
Drug product claim
No
Assignee
IRM LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.